These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27257420)

  • 21. Single fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer.
    Zamboglou C; Rischke HC; Meyer PT; Knobe S; Volgeova-Neher N; Kollefrath M; Jilg CA; Grosu AL; Baltas D; Kroenig M
    J Contemp Brachytherapy; 2016 Jun; 8(3):241-8. PubMed ID: 27504134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer.
    Wazer DE; Berle L; Graham R; Chung M; Rothschild J; Graves T; Cady B; Ulin K; Ruthazer R; DiPetrillo TA
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):889-97. PubMed ID: 12095554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification.
    Vargo JA; Kim H; Houser CJ; Berhane H; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
    Radiother Oncol; 2014 Oct; 113(1):126-31. PubMed ID: 25241996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computed tomography-guided interstitial high-dose-rate brachytherapy in the local treatment of primary and secondary intrathoracic malignancies.
    Tselis N; Ferentinos K; Kolotas C; Schirren J; Baltas D; Antonakakis A; Ackermann H; Zamboglou N
    J Thorac Oncol; 2011 Mar; 6(3):545-52. PubMed ID: 21258257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
    Tselis N; Kolotas C; Birn G; Röddiger S; Filipowicz I; Kontova M; Fountzilas G; Selviaridis P; Baltas D; Heyd R; Anagnostopoulos G; Zamboglou N
    Strahlenther Onkol; 2007 Oct; 183(10):563-70. PubMed ID: 17896088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
    Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of metastatic, imatinib refractory, gastrointestinal stroma tumor with image-guided high-dose-rate interstitial brachytherapy.
    Omari J; Drewes R; Matthias M; Mohnike K; Seidensticker M; Seidensticker R; Streitparth T; Ricke J; Powerski M; Pech M
    Brachytherapy; 2019; 18(1):63-70. PubMed ID: 30385116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation.
    Ricke J; Wust P; Wieners G; Beck A; Cho CH; Seidensticker M; Pech M; Werk M; Rosner C; Hänninen EL; Freund T; Felix R
    J Vasc Interv Radiol; 2004 Nov; 15(11):1279-86. PubMed ID: 15525748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage High-dose-rate Interstitial Brachytherapy for Pelvic Recurrent Cervical Carcinoma After Hysterectomy.
    Murakami N; Kato T; Miyamoto Y; Nakamura S; Wakita A; Okamoto H; Tsuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Takahashi K; Umezawa R; Inaba K; Ito Y; Igaki H; Itami J
    Anticancer Res; 2016 May; 36(5):2413-21. PubMed ID: 27127151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma.
    Jordan SE; Micaily I; Hernandez E; Ferriss JS; Miyamoto CT; Li S; Micaily B
    Brachytherapy; 2017; 16(6):1144-1151. PubMed ID: 28958736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome.
    Jiang P; van der Horst C; Kimmig B; Zinsser F; Poppe B; Luetzen U; Juenemann KP; Dunst J; Siebert FA
    Brachytherapy; 2017; 16(1):186-192. PubMed ID: 28341011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical Trial.
    Murgic J; Morton G; Loblaw A; D'Alimonte L; Ravi A; Wronski M; Davidson M; Haider M; Commisso K; Zhang L; Chung HT
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):561-567. PubMed ID: 30244878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Salvage 125I brachytherapy of locally recurrent prostate cancer].
    Gesztesi L; Ágoston P; Major T; Gődény M; Andi J; Lengyel Z; Polgár C
    Magy Onkol; 2014 Sep; 58(3):219-24. PubMed ID: 25260087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerated partial breast irradiation: a dosimetric comparison of three different techniques.
    Weed DW; Edmundson GK; Vicini FA; Chen PY; Martinez AA
    Brachytherapy; 2005; 4(2):121-9. PubMed ID: 15893265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution study.
    Umezawa R; Murakami N; Nakamura S; Wakita A; Okamoto H; Tsuchida K; Kashihara T; Kobayashi K; Harada K; Takahashi K; Inaba K; Ito Y; Igaki H; Masui K; Yoshida K; Jingu K; Tselis N; Itami J
    Brachytherapy; 2018; 17(2):368-376. PubMed ID: 29275869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy.
    Kolotas C; Tselis N; Sommerlad M; Röddiger S; Schnabel T; Baltas D; Kalogera-Fountzila A; Fountzilas G; Zamboglou N
    Strahlenther Onkol; 2007 Feb; 183(2):69-75. PubMed ID: 17294110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Image-guided interstitial high-dose-rate brachytherapy for dose escalation in the radiotherapy treatment of locally advanced lung cancer: A single-institute experience.
    Chatzikonstantinou G; Zamboglou N; Baltas D; Ferentinos K; Bon D; Tselis N
    Brachytherapy; 2019; 18(6):829-834. PubMed ID: 31500935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward four-dimensional image-guided adaptive brachytherapy in locally recurrent endometrial cancer.
    Fokdal L; Ørtoft G; Hansen ES; Røhl L; Pedersen EM; Tanderup K; Lindegaard JC
    Brachytherapy; 2014; 13(6):554-61. PubMed ID: 25056640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric analysis of 3D image-guided HDR brachytherapy planning for the treatment of cervical cancer: is point A-based dose prescription still valid in image-guided brachytherapy?
    Kim H; Beriwal S; Houser C; Huq MS
    Med Dosim; 2011; 36(2):166-70. PubMed ID: 20488690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.